Entering text into the input field will update the search result below

Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q4 2019 Results - Earnings Call Transcript

Mar. 05, 2020 8:33 PM ETEloxx Pharmaceuticals, Inc. (ELOX)
SA Transcripts profile picture
SA Transcripts

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Q4 2019 Earnings Conference Call March 5, 2020 4:30 PM ET

Company Participants

Barbara Ryan - Investor Relations

Greg Williams - Chief Executive Officer

Tom Haverty - Chief Medical Officer

Matthew Goddeeris - Vice President of Research

Stephen MacDonald - Vice President of Finance and Accounting

Conference Call Participants

Joel Beatty - Citi

Lina Kaminski - Canaccord

Ted Tenthoff - Piper Sandler

Yun Zhong - Janney


Good afternoon, everyone and welcome to Eloxx Pharmaceuticals Fourth Quarter and Full Year 2019 Earnings Webcast and Conference call. Today’s call is being recorded.

At this time, I would like to turn the call over to Barbara Ryan, Eloxx's Investor Relations. Please begin.

Barbara Ryan

Thank you, Gigi. Welcome and thank you for joining us this afternoon for a review of Eloxx Pharmaceutical’s fourth quarter and full year 2019 financial results and business updates.

Joining me this afternoon are Dr. Greg Williams, Chief Executive Officer; Neil Belloff Chief Operating Officer and General Counsel; Tom – Dr. Tom Haverty, our Chief Medical Officer; Dr. Matthew Goddeeris, our VP of Research; and Stephen MacDonald our Vice President of Finance and Accounting.

Before we begin I'd like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these statements as a result of various important factors including those discussed in the Risk Factors section in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission and our other reports filed with the SEC. Any forward-looking statements represent our views as of today March 5, 2020 only. A replay of this call will be available on the company's website www.eloxxpharma.com following

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.